Scarica l'app Stockscreener
1.83
1.61%
-0.03
Precedente Chiudi:
$1.86
Aprire:
$1.86
Volume 24 ore:
8,784
Relative Volume:
0.07
Capitalizzazione di mercato:
$92.07M
Reddito:
$63.69M
Utile/perdita netta:
$-44.82M
Rapporto P/E:
-0.915
EPS:
-2
Flusso di cassa netto:
$-30.56M
1 W Prestazione:
-2.14%
1M Prestazione:
-8.04%
6M Prestazione:
-44.04%
1 anno Prestazione:
-47.86%
Intervallo 1D:
$1.82
$1.86
Intervallo di 1 settimana:
$1.82
$2.01
Portata 52W:
$1.55
$3.85
Mdxhealth Sa Stock (MDXH) Company Profile
Nome
Mdxhealth Sa
Settore
Industria
Telefono
-
Indirizzo
-
Confronta MDXH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
1.83 | 92.07M | 63.69M | -44.82M | -30.56M | -2.00 |
|
TMO
Thermo Fisher Scientific Inc
|
537.43 | 205.72B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
212.32 | 149.54B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
136.53 | 39.02B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
460.38 | 37.08B | 3.90B | 887.87M | 808.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
195.01 | 34.17B | 15.41B | 1.37B | 2.11B | 7.50 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-31 | Iniziato | Lake Street | Buy |
| 2023-05-31 | Iniziato | TD Cowen | Outperform |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
Mdxhealth Sa Borsa (MDXH) Ultime notizie
MDxHealth (MDXH) Projected to Post Earnings on Wednesday - Defense World
Mdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26 - The Manila Times
MDxHealth Earnings Alert: Key Financial Results & Strategic Updates Unveiled Next Week - StockTitan
MDxHealth SA Provides Revenue Guidance for the Fourth Quarter of 2024, Full Year of 2024 and Year 2025 - Marketscreener.com
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance - The Manila Times
MDxHealth Reports Strong 28% Revenue Growth, Projects EBITDA Profitability in 2025 - StockTitan
Contrasting Biodesix (NASDAQ:BDSX) & MDxHealth (NASDAQ:MDXH) - Defense World
Critical Survey: BioNexus Gene Lab (NASDAQ:BGLC) versus MDxHealth (NASDAQ:MDXH) - Defense World
MDxHealth: Strong Buy On Its Cutting-Edge Urology Diagnostics (NASDAQ:MDXH) - Seeking Alpha
MDxHealth (STU:O6C1) Enterprise Value : €88.51 Mil (As of Dec. 08, 2024) - GuruFocus.com
MDxHealth SA (NASDAQ:MDXH) Q3 2024 Earnings Call Transcript - MSN
MDxHealth (CHIX:MDXHB) Enterprise Value : €102.00 Mil (As of Dec. 01, 2024) - GuruFocus.com
MDxHealth to Participate in Piper Sandler Healthcare Conference - The Manila Times
MDxHealth CEO to Present at Piper Sandler Healthcare Conference in NYC | MDXH Stock News - StockTitan
OneDigital Investment Advisors LLC Increases Stock Position in MDxHealth SA (NASDAQ:MDXH) - Defense World
MVM Partners, LLC Reduces Stake in Paragon 28 Inc - GuruFocus.com
MDxHealth SA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
MDxHealth stock hits 52-week low at $1.57 amid market challenges By Investing.com - Investing.com South Africa
MDxHealth stock hits 52-week low at $1.57 amid market challenges - Investing.com
OC500 2024: Michael McGarrity - Orange County Business Journal
AWM Investment Company's Strategic Acquisition of MDxHealth SA S - GuruFocus.com
MDxHealth stock hits 52-week low at $1.93 amid market challenges - Investing.com
MDxHealth SA (MDXH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... - Yahoo Finance
MDxHealth SA (MDXH) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
MDxHealth ADR earnings missed by $0.13, revenue topped estimates - Investing.com
MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024 - The Manila Times
What To Expect From MDxHealth SA (MDXH) Q3 2024 Earnings - GuruFocus.com
MDxHealth (OTCMKTS:MXDHF) Trading Down 9.1% – Here’s Why - Defense World
Lake Street Initiates Coverage of MDxHealth (MDXH) with Buy Recommendation - MSN
MVM Partners, LLC Increases Stake in MDxHealth SA - GuruFocus.com
Liquid Biopsy Market Set for Explosive Growth by 2024-2031: Key Trends and Drivers | MDxHealth SA, Natera, Inc - EIN News
MdxHealth’s US$40 Million Ordinary Shares Offering - Global Legal Chronicle
MDxHealth stock hits 52-week low at $1.95 amid market challenges - Investing.com
Critical Analysis: MDxHealth (NASDAQ:MDXH) & Aclarion (NASDAQ:ACON) - Defense World
MDxHealth to Present Third Quarter 2024 Financial Results and Corporate Update on November 6 - The Manila Times
DLA Piper advises TD Cowen as underwriter in MdxHealth’s US$40 million public offering of ordinary shares - Legal Desire News Network
Midday Stock Roundup: STAAR Surgical CO. Shares Surge 22% - Orange County Business Journal
MDxHealth announces pricing of registered public offering - Medical Buyer
mdxHealth stock touches 52-week low at $2.0 amid market challenges - Investing.com Australia
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.62% - MSN
MDXH’s Market Whiplash: -48.98% YTD Decline, -31.40% Plunge in 30 Days - The InvestChronicle
Dow Surges Over 250 Points; Accenture Earnings Top Views - Benzinga
MDXH’s price-to-book ratio: An indicator of the company’s performance - US Post News
Crude Oil Down Over 2%; US Initial Jobless Claims Fall - Benzinga
Mdxhealth Sa Azioni (MDXH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.05%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):